sulfonylurea vs glp 1 Diabetic Agents, From Metformin to SGLT2 Inhibitors and GLP1 Receptor Agonists: JACC Focus Seminar MED 360 | 💊 ANTI-DIABETIC

More importantly, the weight loss associated with GLP-1s is not a welcome symptom in a disease were slowly progressive wasting is common concern

The wife had a strong fear of emotional rejection because she had grown up feeling ignored in her own family

The health benefits for infants, reduced infections, improved immune function, potential long-term metabolic benefits, are well established

GLP-1 agonists arent likely to cause low blood sugar levels or hypoglycemia when used alone

Reference: Huang H et al

Patients with a history of cholecystectomy (gallbladder removal) face no additional gallstone risk from GLP-1 therapy, as they have no gallbladder to form stones